Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial-Reference-Cited by-同舟云学术

Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial

Published:2018-04 Issue:4 Volume:5 Page:e172-e180
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Molina Jean-Michel,Grund Birgit,Gordin Fred,Williams Ian,Schechter Mauro,Losso Marcello,Law Matthew,Ekong Ernest,Mwelase Noluthando,Skoutelis Athanasios,Wiselka Martin J,Vandekerckhove Linos,Benfield Thomas,Munroe David,Lundgren Jens D,Neaton James D

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference27 articles.

1. Initiation of antiretroviral therapy in early asymptomatic HIV infection;Lundgren;N Engl J Med,2015

2. A trial of early antiretrovirals and isoniazid preventive therapy in Africa;Danel;N Engl J Med,2015

3. Prevention of HIV-1 infection with early antiretroviral therapy;Cohen;N Engl J Med,2011

4. Risk of HIV transmission in serodifferent couples not using condoms when the HIV positive partner is using suppressive antiretroviral therapy;Rodger;JAMA,2016

5. An updated coronary risk profile. A statement for health professionals;Anderson;Circulation,1991

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between long-term exposure to fine particulate matter and its chemical constituents and premature death in individuals living with HIV/AIDS;Environmental Pollution;2024-06

2. Incomplete recovery of the CD4+/CD8+ ratio is associated with the late introduction of antiretroviral therapy among people living with HIV infection;Revista do Instituto de Medicina Tropical de São Paulo;2024

3. HIV-1 infection in South Kivu (Democratic Republic of Congo): high genotypic resistance to antiretrovirals;Journal of Antimicrobial Chemotherapy;2023-05-31

4. Human Immunodeficiency Virus Viral Load Monitoring and Rate of Virologic Suppression Among Patients Receiving Antiretroviral Therapy in Democratic Republic of the Congo, 2013–2020;Open Forum Infectious Diseases;2023-05-03

5. CD4/CD8 Ratio During Human Immunodeficiency Virus Treatment: Time for Routine Monitoring?;Clinical Infectious Diseases;2023-03-08